Robomed Network | Connecting patients and healthcare providers with smart contracts
Connecting patients and healthcare providers with smart contracts Your personal treatment safeguard
Whitepaper Telegram Blog
Buy RBM tokens
Stage 1 is successfully completed. Keep in touch!

Medical error is third leading cause of death


Automated patient safety and heathcare quality check with smart contracts based on clinical guidelines

What is Robomed Network

Robomed Network issues its own tokens to support smart contract between healthcare providers and patients. RBM smart medical contract elevates service value by granting its owner full accomplishment of clinical guidelines for specific case by healthcare provider. Robomed clinical guidelines are subject to constant improvement by the professional medical community, motivated for higher goals and bonuses by Robomed Network.

Our background

Robomed EHR beta 1Q 2016
Open API 2Q 2016
1st clinic connected 4Q 2016
1 mln patients in database 1Q 2017
Smart contract developed 2Q 2017
Token emission 4Q 2017
3 software products developed
20 clinics connected
1,7 mln clients in database
2900 clinical guidelines digitalized
Actual doctors get paid at this moment for treating patients according to guidelines

Our team

William Peckham (孙哲安) Business strategy development

Partner and Investment Director at Central Capital, a boutique investment management company built out of a family office in Beijing. He serves as an active advisor to Sdeals, an inventory clearance tech startup, as well as advisor to numerous other local and foreign tech startups in China.

Jean-Elie Malkin Medical director

Senior medical expert. Ex-Director of Global Alliance for Health and Social Compact (GAHSC). Highly experienced in building relationship with political decision makers at highest level: Presidents, Prime Ministers, Ministers of Health and Finance. Proficient in development, implementation and management of various managed care programmes.

Philipp Mironovich Co-founder

The founder of several projects in medicine and IT. 7 years of successful entrepreneurship in the medical market, finalist of the EY 2015 "Entrepreneur of the Year" award.

Andreas Kumbroch CTO

Mr. Kumbroch serve as Managing Director by Allocate Software GmbH and is responsible for the German, Swiss and Austria market. Ex-Managing Director for Strategy Business Development by Compugroup Medical in the LAB Segment and before Compugroup take over vision4health Laufenberg & January 2014, Mr. Kumbroch co-founded vision4health GmbH & Co. KG in June 2007 and serves as its Chief Executive Officer and shareholder.

Caroline Maslo Medical expert

Dr Caroline Maslo is a Medical Doctor. She holds a PhD and has over 20 years’ experience in clinical practice at the Paris’ hospital group “Assistance Publique-Hȏpitaux de Paris”. In 2003, she moved to South Africa and launched an HIV clinic in Soweto. In 2005, she moved to the private sector and has been working in the quality leadership and disease management area for the last 12 years.

Ivan Devyatkov Co-founder

Healthcare sector expert, 9 years of working experience in healthcare sector with western IT companies, transforming the knowledge onto the Russian Market. In the past involved in building the second biggest Laboratory player on the Russian market from scrap through automation, scaling and multiplication of the business model and selling it to Western equity funds and EBRD.

Vasily Kuznetsov Marketing & Events

Co-Founder of the biggest Russian blockchain community. Experienced tech entrepreneur. High level of proficiency in marketing and community management.

Maria Agranovskaya Legal

Attorney at Law with 20+ years of experience. M&A, other transactions in insurance, banking, energy, telecom and other sectors - tax optimisation and structuring management of more than 200 companies. Substantially engaged in blockchain technology and ICO (TGE) related projects. Fluent in English, German, French, Italian, Spanish.

Our advisors

Тhomas W.

Thomas W. Feeley, M.D. is a Senior Fellow at the Harvard Business School. He headed the Institute for Cancer Care Innovation at the University of Texas MD Anderson Cancer Center until 2017.

Anthony Provasoli

Partner at the law firm Hassans. Manages the department of blockchain projects. Specializes on Gibraltar-base ICOs.

Philip McMaster (“DaLong” in China)

Global advocate for Blockchain Technology and Individual Social Responsibility (ISR), Philip understands the need for Robomed as someone who has required and used medical services from Mount Everest to big cities in China and the Brazilian Amazon. Philip appreciates medical personnel standards of authenticity, health science background, compassionate judgement and experience with cultural differences and pressure.

Yury Krestinskiy

Director of Skolkovo Health Economics and Management Centre, owner of Bionika group. Started his first business in 1991 in the publishing industry, came to healthcare and pharmaceutical industry in 1992 as the head of one of the first wholesale companies in Russia.
Yury invests in highly diversified projects embracing film production, fitness industry, venture projects and helps young entrepreneurs actively.

How does it work

Clinic guildelines
not accomplished
Robomed Network

Treatment is controlled by Robomed smart contract

Smart contract

Controlled by international medical guideline

Robomed Network

Treatment is controlled by Robomed smart contract

Smart contract

Controlled by international medical guideline

How does Robomed get guidelines?

Identification, verification of license / certificate


Reward for voice in RBM

Creation and voting for updated metrics of clinical pathway standards

Rating of cases Knowledge database Patients

Reward for voice in RBM

Voting for the priorities of updating the standards

Variety of cases

Market overview

Money spending per person in the world
  • High non-medical costs
  • High R&D capacity
  • Great infrastructure
  • Mostly skilled medical staff
  • Sufficient infrastructure
  • Low R&D capacity
  • Rare skilled medical staff
  • Pay out of pocket for better care
$4600 BN market size
  • 36% - North America
  • 28% - European Union
  • 22% - East Asia & Pacific
  • 4% - Latin America & Caribbean
  • 4% - Central Asia
  • 2% - India
  • 2% - Middle East & North Africa
  • 2% - Arab world
$800 BN target market
  • 61% - Public
  • 28% - Total spent out of pocket
  • 10% - Spent by private insurance
  • 1% - External help

Economic model

Intended use of ICO funding
  • 70% - Provision fund
  • 15% - Development
  • 10% - Marketing
  • 3% - Operations
  • 2% - Legal
Use of operational revenue
  • 54% - Marketing
  • 17% - Profit
  • 12% - Development
  • 9% - R&D
  • 6% - Operations
  • 2% - Legal

Our partners

ICO milestones
eth raized milestone
  • 50 000 25 000
    Stage 6 We cover USA
  • 50 000 25 000
    Stage 5 We cover West Asia / Australia / Oceania
  • 50 000 25 000
    Stage 4 We cover Western Europe
  • 50 000 25 000
    Stage 3 We cover Latin America
  • 50 000 25 000
    Stage 2 We cover East Asia
  • 100 000 75 000 50 000 25 000
    Stage 1 We cover East Europe 100% development + operations 75% development
Token distribution
  • 70% - Purchasers
  • 25% - Long term endowment/Foundation
  • 5% - Early contributors and founders

Founders have 2 year vesting, with 6 months cliff Early contributors have 6 months vesting, with 3 months cliff

Bonus scale ICO
Base price 1 ETH = 2078 RBM
Sale price 1 ETH = 2702 RBM
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
ICO Tokens Sold %


07 sept
Blockchain & Bitcoin Conference Stockholm, Sweden
25 sept
World Blockchain Forum - Investments & ICOs London, UK
26 sept
Blockchain Middle East Forum Dubai, UAE
13 sept
Blockchain & Bitcoin Conference Stockholm, Sweden
24 sept
World Block Chain Summit Dubai, UAE


  • How will behave the RBM currency after entering the market?
    • At the project development stage, until the demand for value-oriented medical services reaches the saturation limit, it is expected that monthly purchases of RBM will exceed RBM sales (exchange for other currencies). Thus, the price of RBM will grow over the long term, backed by the real product fulfilment with confirmed demand.

  • Why do you think people will buy RBM smart medical contacts?
    • The answer is simple but perhaps may not be obvious to everyone. Healthcare is ought to be driven by a relentless focus on delivering outcomes that truly matter to patients and to society in a financially sustainable manner. But this is hard to do and hard to manage when the patient outcomes we should deliver are not clearly defined. Also, costs are increasing unsustainably with a significant fraction of healthcare spending wasted on low-value diagnostic procedures or treatments and on consequences of clinical errors. By eliminating inefficiencies, we can save approximately $1 trillion globally each year. Imagine the possibilities if we were to invest that capital in meaningful innovation or disease prevention. When it comes to out of pocket spending – nobody wants to waste his money or time. Our tool appears to be quite useful here.

  • How do you plan creating those much clinical guidelines and keep them up to date?
    • The Robomed Network includes a tool for decentralized management of the criteria for the effectiveness of medical services. The active involvement of the professional medical community will be motivated by RBM payments for each vote, and the competence of holders of RBM Tokens admitted to professional medical voting will be checked throughout the authorization process. We believe that combined knowledge of professional medical community is there to help. We already have 2900 clinical guidelines digitalized.

  • What if some hospital doesn’t want to install your EHR?
    • In case that the medical service provider does not want to work in the Robomed EHR, it can use any other EHR system and connect to the Robomed Network using the dedicated API under condition of the observation of the communication protocols according to the HL7 standard (or FHIR).

  • Who exactly is your customer?
    • Our customer is an individual with a health problem with no insurance plan. He is willing to find the best solution for problem in a limited time and money. We provide this solution.

  • What if during RBM smart contact fulfillment an unusual result occurs?
    • Although 90% of clinical cases are routine, such a thing can rarely happen. In that situation, this patient’s EMR with all his data except identity will become a subject to investigation by Robomed Network medical community with top priority.

  • How will you measure clinical guideline accomplishment by healthcare provider?
    • Each clinical guideline consists of crucial milestones: completed services and medical data. Reference values of these milestones are the core of outcome measurement in Robomed EHR. Real time capture and reliability of block chain technology provides trustworthy information for such measurement.

  • What is a smart contract?
    • Smart contracts are computer protocols intended to facilitate, verify, or enforce the negotiation or performance of a contract. Proponents of smart contracts claim that many kinds of contractual clauses may be made partially or fully self-executing, self-enforcing, or both. The aim of smart contracts is to provide security that is superior to traditional contract law and to reduce other transaction costs associated with contracting.